Detection of Germline Mutations in Breast Cancer Patients with Clinical Features of Hereditary Cancer Syndrome Using a Multi-Gene Panel Test
Cancer Research and Treatment. 2020;52(3):697-713 
Sequence-based detection of mutations in cadherin 1 to determine the prevalence of germline mutations in patients with invasive lobular carcinoma of the breast
Hereditary Cancer in Clinical Practice. 2014;12(1):
Use of multi gene-panel testing to detect hereditary breast cancer gene variants in patients attending to a breast cancer clinic, Peradeniya, Sri Lanka
European Journal of Cancer. 2020;138:S80
High Prevalence of Germline Mutations in Cancer Susceptibility Genes in Thai Patients with Clinical Spectrum of Hereditary Breast-Ovarian Cancer Syndrome
. 2020;
Psychological and health behaviour outcomes following multi-gene panel testing for hereditary breast and ovarian cancer risk: a mini-review of the literature
Hereditary Cancer in Clinical Practice. 2022;20(1):
Clinical Features of Breast Cancer in South Korean Patients with Germline TP53 Gene Mutations
Journal of Breast Cancer. 2021;24(2):175
BRCA1 andBRCA2 germline mutations in Japanese with hereditary breast cancer families
Breast Cancer. 1997;4(4):256-258
Germline mutations in theRB1 gene in patients with hereditary retinoblastoma
Genes, Chromosomes and Cancer. 1995;14(4):277-284
Germline MUTYH gene mutations are not frequently found in unselected patients with papillary breast carcinoma
Hereditary Cancer in Clinical Practice. 2014;12(1):
Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2
Cancers. 2020;12(9):2415